Unnamed: 0,Industry,GRI Code,GRI Name,Disclosure,Disclosure Name,General Information,Initiative,Initiative from the undisclosed GRI (found by the coder but not mentioned in the GRI index table),UNDISCLOSED GRI,Organisation,Year,Solution Description,Solution Outcome,Digital tool,Data Source,Unnamed: 15,Unnamed: 16,Unnamed: 17,Keywords,SDGs,ESG,UNGC,Notes,Unnamed: 23,Unnamed: 24,Unnamed: 25,Unnamed: 26,Unnamed: 27,Unnamed: 28,Unnamed: 29,Unnamed: 30,Unnamed: 31,Unnamed: 32,Unnamed: 33,Unnamed: 34,Unnamed: 35,Unnamed: 36
148,,403.0,Occupational Health and Safety,403-10,Work-related ill health,,,,NO DISCLOSURE,CSL,2023.0,,,,,,,,,,,,,,,,,,,,,,,,,,
149,,404.0,Training and Education,404-01,Average hours of training per year per employee,,,,NO DISCLOSURE,CSL,2023.0,,,,,,,,,,,,,,,,,,,,,,,,,,
150,,404.0,Training and Education,404-02,Programs for upgrading employee skills and transition assistance programs,,Management Development,,,CSL,2023.0,"Management Essentials is a program for managers and senior managers across all business areas. Topics include the role of a leader, building trust, communication and feedback, coaching, change and inclusive leadership with a focus on the individual biases that affect relationships, collaboration and performance.",,,,,43,,"Upgrading, Management, Development",481016.0,S,,,,,,,,,,,,,,,,
151,,404.0,Training and Education,404-02,Programs for upgrading employee skills and transition assistance programs,,High Potential Talent Development,,,CSL,2023.0,"The CSL Executive Edge program accelerates the development of high-potential senior leaders to help prepare them for executive roles. The program focuses on leading strategy and people with an enterprise and inclusive mindset. It offers an immersive in-market experience, executive exposure and networking, and engagement in a strategic project tied to the company's strategy.",,,,,42,,"Potential, Talent, Development",81016.0,S,,,,,,,,,,,,,,,,
152,,404.0,Training and Education,404-02,Programs for upgrading employee skills and transition assistance programs,,Leadership Development,,,CSL,2023.0,"Leadership Excellence is a program specially designed for associate directors and directors across all areas of our business. It also includes business simulations, peer learning activities and reverse mentoring to broaden participant perspectives.",,,,,43,,"Upgrading, Development, Leadership",81016.0,S,,,,,,,,,,,,,,,,
153,,404.0,Training and Education,404-03,Percentage of employees receiving regular performance and career development reviews,More than 500 colleagues Ã¢ÂÂ 47% women Ã¢ÂÂ participate in our global mentoring program.,,,,CSL,2023.0,,,,,,42,,,,,,,,,,,,,,,,,,,,
154,,405.0,Diversity and Equal Opportunity,405-01,Diversity of governance bodies and employees,"In alignment with ASX Corporate Governance Council Principles, we have established measurable long-term gender goals: 30% or better of each gender represented on our Board of Directors, 50% women among our People Manager population by 2025 and 40% women among our Senior Executives by 2030.",,,,CSL,2023.0,,,,,,41,,,,,,,,,,,,,,,,,,,,
155,,405.0,Diversity and Equal Opportunity,405-02,Ratio of basic salary and remuneration of women to men,,,,NO DISCLOSURE,CSL,2023.0,,,,,,,,,,,,,,,,,,,,,,,,,,
156,,406.0,Non-discrimination,406-01,Incidents of discrimination and corrective actions taken,,,,NO DISCLOSURE,CSL,2023.0,,,,,,,,,,,,,,,,,,,,,,,,,,
157,,407.0,Freedom of Association and Collective Bargaining,407-01,Operations and suppliers in which the right to freedom of association and collective bargaining may be at risk,,,,NO DISCLOSURE,CSL,2023.0,,,,,,,,,,,,,,,,,,,,,,,,,,
158,,408.0,Child Labor,408-01,Operations and suppliers at significant risk for incidents of child labor,"CSL recognises that we are responsible for respecting the rights of all individuals we interact with, including our patients, clinical trial participants, plasma donors, healthcare professionals, and employees. CSL complies with the minimum age labour requirements in every country we operate.",,,,CSL,2023.0,,,,,,,,,,,,Location from Human Right Statement page 1,,,,,,,,,,,,,,
159,,409.0,Forced or Compulsory Labor,409-01,Operations and suppliers ar significant risk for incidents of forced or compulsory labor,"From 1 July 2022 to 30 June 2023, no reports related to human trafficking or slavery and forced labour in CSL's global operations were received.",,,,CSL,2023.0,,,,,,54,,,,,,,,,,,,,,,,,,,,
160,,410.0,Security Practices,410-01,Security personnel trained in human rights policies or procedures,,,,NO DISCLOSURE,CSL,2023.0,,,,,,,,,,,,,,,,,,,,,,,,,,
161,,411.0,Rights of Indigenous Peoples,411-01,Incidents of violations involving rights of indigenous peoples,,,,NO DISCLOSURE,CSL,2023.0,,,,,,,,,,,,,,,,,,,,,,,,,,
162,,412.0,Human Rights Assessment,412-01,Operations that have been subject to human rights reviews or impacts assessments,"Where CSL is working with other third parties and manufacturers of products and services that form part of our total supply chain, CSL expects their policies and practices to respect these rights similarly. CSL will partner with stakeholders, including industry associations and government and non-government organisations (NGOs), where practical and of mutual benefit, to continually improve its suppliers' and partners' human rights practices.",,,,CSL,2023.0,,,,,,,,,,,,Location from Human Right Statement page 1,,,,,,,,,,,,,,
163,,412.0,Human Rights Assessment,412-02,Employee training on human rights policies or procedures,"CSL's researchers and employees are dedicated to conducting our clinical trials by consensus ethical principles derived from international ethics guidelines, such as the International Council for Harmonisation (ICH). Guideline for Good Clinical Practice (GCP), the World Medical Association Declaration of Helsinki, and the CIOMS International Ethical Guidelines for Biomedical Research Involving Human Subjects.",,,,CSL,2023.0,,,,,,,,,,,,Location from Human Right Statement page 3,,,,,,,,,,,,,,
164,,412.0,Human Rights Assessment,412-03,Significant investment agreements and contracts that include human rights clauses or that underwent human rights screening,,,,NO DISCLOSURE,CSL,2023.0,,,,,,,,,,,,,,,,,,,,,,,,,,
165,,413.0,Local Communities,413-01,"Operations with local community engagement, impact assessments, and development programs",,The role of real-world evidence in driving vaccine value and access,,,CSL,2023.0,"As a company on the front line of influenza prevention, CSL Seqirus is committed to using RWE to continually evaluate the clinical benefit and cost-effectiveness of our innovative seasonal influenza vaccines compared to more traditional options. RWE can be a valuable tool in helping health agencies decide which influenza vaccines to recommend for specific populations, providing access to the most vulnerable groups through government-funded immunization programs.",,,,,56,,"Engagement, Vaccination, Health",3.17,S,,,,,,,,,,,,,,,,
166,,413.0,Local Communities,413-01,"Operations with local community engagement, impact assessments, and development programs",,CSL ViforÃ¢ÂÂs commitment to patients through the Patient Academy,,,CSL,2023.0,"The CSL Vifor Patient Academy offers employees the unique opportunity to learn directly from patient representatives about the disease burden they carry and the importance of involving patients' insights in critical strategic decisions, from clinical development programs to the development of patient support programs. When engaging directly with patients, we follow strict engagement protocols and apply standardized remuneration principles.",,,,,56,,"Patient, Academy, Engagement",3.17,S,,,,,,,,,,,,,,,,
167,,413.0,Local Communities,413-01,"Operations with local community engagement, impact assessments, and development programs",,Plasma Donors,,,CSL,2023.0,"As one of the world's largest producers of plasma-derived therapies and a leader in plasma collection, CSL Plasma commits to excellence and innovation across the entire cycle of plasma donation, from donor screening throughout the donation process and across plasma testing and logistics. About 15,000 CSL Plasma employees ensure safety. Quality plasma can be manufactured into life-saving therapies.",,,,,57,,"Engagement, Plasma, Transfusion",3.17,S,,,,,,,,,,,,,,,,
168,,413.0,Local Communities,413-02,Operations with significant actual and potential negative impacts on local communities,,,,NO DISCLOSURE,CSL,2023.0,,,,,,,,,,,,,,,,,,,,,,,,,,
169,,414.0,Supplier Social Assessment,414-01,New suppliers that were screened using social criteria,,Supply Chain Legislation Training,,,CSL,2023.0,"Supply chain legislation training refers to educational programs and initiatives to inform individuals, particularly those involved in supply chain management, procurement, and related fields, about relevant laws, regulations, and compliance requirements governing supply chain practices. This training ensures that professionals understand their legal obligations, mitigate risks, and adhere to ethical standards in managing supply chain operations.",,,,,54,,"Supply chain, Legislation, Training",10.16,S,,,,,,,,,,,,,,,,
170,,414.0,Supplier Social Assessment,414-02,Negative social impacts in the supply chain and actions taken,"Anyone with information about potential misconduct is encouraged to 'Speak Up' under the CSL Speak Up Policy. It includes CSL's current and past employees, directors, contractors, customers, suppliers and associates. All reports made under this policy are received, treated sensitively and thoughtfully, and dealt with promptly, fairly, and objectively.",,,,CSL,2023.0,,,,,,54,,,,,,,,,,,,,,,,,,,,
171,,415.0,Public Policy,415-01,Political contributions,"Over the reporting period, CSL contributed a total of US$1,000 in non-cash corporate political contributions in the United States and A$5,500 to political organisations in Australia solely for attendance at events, including policy briefings, lunches, boardroom lunches and dinners. In all other regions, CSL made no political contributions.",,,,CSL,2023.0,,,,,,69,,,,,,,,,,,,,,,,,,,,
172,,416.0,Customer Health and Safety,416-01,Assessment of the health and safety impacts of product and service categories,"In 2022/23, CSL's quality systems, plasma collection and manufacturing operations were subject to 473 regulatory agency inspections worldwide. Of these, 21 good manufacturing practice (GMP) regulatory agency inspections occurred at our manufacturing facilities, and 452 regulatory inspections occurred at our plasma collection centres.",,,,CSL,2023.0,,,,,,53,,,,,,,,,,,,,,,,,,,,
173,,416.0,Customer Health and Safety,416-02,Incidents of non-compliance concerning the health and safety impacts of products and services,,,,NO DISCLOSURE,CSL,2023.0,,,,,,,,,,,,,,,,,,,,,,,,,,
174,,417.0,Marketing and Labeling,417-01,Requirements for product and service information and labeling,,,,NO DISCLOSURE,CSL,2023.0,,,,,,,,,,,,,,,,,,,,,,,,,,
175,,417.0,Marketing and Labeling,417-02,Incidents of non-compliance concerning product and service information and labeling,"This year, there were 11 counterfeit products reported to and confirmed by CSL Behring. CSL Behring is evaluating opportunities to increase the security of packaging solutions to prevent counterfeiting.",,,,CSL,2023.0,,,,,,53,,,,,,,,,,,,,,,,,,,,
176,,417.0,Marketing and Labeling,417-03,Incidents of non-compliance concerning marketing communications,,,,NO DISCLOSURE,CSL,2023.0,,,,,,,,,,,,,,,,,,,,,,,,,,
177,,418.0,Customer Privacy,418-01,Substantiated complaints concerning breaches of customer privacy and losses of customer data,,Monitoring and Assessing Cybersecurity Threats,,,CSL,2023.0,CSL recognizes the escalating risk of cyber threats and data privacy breaches targeting individuals and organizations. CSL maintains a proactive stance by continuously monitoring and assessing cybersecurity threats.,,,,,27,,"Cyber Security, Monitoring, Threats",8.9,S,,,,,,,,,,,,,,,,
178,,418.0,Customer Privacy,418-01,Substantiated complaints concerning breaches of customer privacy and losses of customer data,,Robust Security Control,,,CSL,2023.0,"Breaches of CSL information technology (IT) security and unauthorized or inadvertent release of information caused by human error, malware or espionage may compromise the privacy and security of our data. CSL has designed and implemented robust security controls for its IT systems, infrastructure, and data based on understanding known threats, industry best practices, and external testing to ensure their effectiveness.",,,,,27,,"Robust, Security, Control",9.0,S,,,,,,,,,,,,,,,,
179,,418.0,Customer Privacy,418-01,Substantiated complaints concerning breaches of customer privacy and losses of customer data,,Training Program,,,CSL,2023.0,"Furthermore, CSL understand that awareness and preparedness are key in responding to cyberattacks and safeguarding data privacy. As such, CSL places great emphasis on providing ongoing education and training to their employees.",,,,,27,,"Cyber Training, Employee. Cyberattacks",4.9,S,,,,,,,,,,,,,,,,
180,,419.0,Socioeconomic Compliance,419-01,Non-compliance with laws and regulations in the social and economical area,,,,NO DISCLOSURE,CSL,2023.0,,,,,,,,,,,,,,,,,,,,,,,,,,
183,,,Total disclosure,88,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
184,,,Total no of reported disclosure over maximum disclosure (source:GRI index),88/122,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
185,,,Average completion rate,0.721311,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
186,,,Maximum disclosure,122,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
